BGI will start offering quantitative RNA-seq services on the BGISEQ-500 soon, followed by whole-genome sequencing later this year.
Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco.
The research used multiple genetic analyses on samples collected over 29 years to show changes associated with disease progression.
The new division will enable BGI to expand partnerships with universities, companies, and health and agriculture-related organizations, among other things.
The study is the first published data of BGI's desktop sequencer, BGISEQ-500, which German researchers are studying for use in evaluating microRNA biomarkers.
The researchers reported that about three quarters of the 10-gigabase ginkgo genome consists of repeat sequences.
The new BGISEQ-50, a smaller version of the BGISEQ-500, will have research and clinical applications, and BGI plans to register it with the CFDA, too.
The partners are planning a joint research center at Providence Health Care's St. Paul's Hospital in Vancouver and a center of excellence in China.
Researchers established a high-quality version of the five-pacer viper genome and used it to take a wider look at snake relationships and adaptations.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.